Skip to main content

Table 1 Sidak's multiple Comparisons test for six groups based on antibody levels in sera at 42 days after immunization. p< 0.0001(****), 0.0002(***), 0.0021(**) indicated significant differences

From: Designing of novel chimeric PvpA-pMGA protein of Mycoplasma gallisepticum, applicable for indirect ELISA

Sidak's multiple comparisons test

Mean Diff.

95% CI of Diff.

Significant?

Summary

Adjusted p Value

  

Adj vs. PBS

0.2667

-0.2617 to 0.7950

No

ns

0.725778

B-A

 

Ts-11 vs. adj

0.6783

0.15 to 1.207

Yes

**

0.005795

C-B

 

S6 vs.adj

0.7083

0.18 to1.237

Yes

**

0.003686

D-B

 

rPro1 vs. adj

1.540

1.012 to 2.068

Yes

****

<0.000001

E-B

 

rPro2 vs. adj

1.715

1.187 to 2.243

Yes

****

<0.000001

F-B

 

rPro2 vs. Ts-11

1.037

0.5083 to 1.565

Yes

****

0.000022

F-C

 

rPro2 vs. s6

1.007

0.4783 to 1.535

Yes

****

0.000036

F-D

 

rPro2 vs. rPro1

0.1750

-0.3533 to 0.7033

No

ns

0.963656

F-E

 

Test details

Mean 1

Mean 2

Mean diff.

SE of diff.

n1

n2

t

Adj vs. PBS

0.5700

0.3033

0.2667

0.1802

6

6

1.480

Ts-11 vs. adj

1.248

0.5700

0.6783

0.1802

6

6

3.764

S6 vs.adj

1.278

0.5700

0.7083

0.1802

6

6

3.931

rPro1 vs. adj

2.110

0.5700

1.540

0.1802

6

6

8.546

rPro2 vs. adj

2..285

0.5700

1.715

0.1802

6

6

9.518

rPro2 vs. Ts-11

2.285

1.248

1.037

0.1802

6

6

5.753

rPro2 vs. s6

2.285

1.278

1.007

0.1802

6

6

5.587

rPro2 vs. rPro1

2.285

2.11

0.1750

0.1802

6

6

0.9712